Multiple risk factors for BPH progression have been identified; prostate volume, prostate-specific antigen (PSA), peak flow rate (Qmax), post-void residual volume, age, and symptom scores have been associated with an increased risk of clinical progression [3]. Here, KLK3 is linked to benign prostatic hyperplasia.